Explore our ACCC 2020 Impact Report, the Oncology Issues, Vol.36, N.3, and our video podcast, CANCER BUZZ TV.
New PAG Website Button



In This Section

Home / Learn / Publications / Patient Assistance and Reimbursement Guide

Patient Assistance and Reimbursement Guide

Updated April 2021

The spring update to the 2021 Patient Assistance & Reimbursement Guide has the most up-to-date information on cancer drug assistance and reimbursement programs to help your patients alleviate the financial burden of their treatment.

This guide to financial assistance contains directions on program enrollment from 45 companies, granting eligible insured, underinsured, and uninsured patients access to more than 180 oncology medications at little or no cost, including new programs for EMD Serono, G1 Therapeutics, and Oncopeptides.

The 2021 Patient Assistance & Reimbursement Guide contains:

  • A message from ACCC Board of Trustees Member and OPEN Advisory Committee Member Jorge J. García, PharmD, MS, MHA, MBA, FACHE.
  • A feature article written by fellow ACCC members to assist those new to their role in helping their patients access financial assistance.
  • An updated “Financial Navigation Flowchart” to help all financial advocates streamline their workflows.
  • A Quick Reference Guide updated to include all new oncology-related products, companies, and linked assistance websites.

The print version of the 2021 Patient Assistance & Reimbursement Guide was mailed to ACCC Members in January 2021.

Email your comments and feedback to Maddelynne Parker, ACCC Content Coordinator.


Also from the patient assistance guide

From the ACCC Financial Advocacy Network

COVID-19 Financial Advocacy Resources


Other Financial Advocacy Resources

Our Financial Advocacy Boot Camp offers a dynamic online curriculum that helps you and your cancer patients navigate the complex healthcare system and pay for their treatment. Learn more about how to be an effective financial advocate.

Learn More

The ACCC Oncology Drug Database contains billing and diagnosis codes, reimbursement amounts, FDA-approved indications, and contact information for every cancer drug on the market.

Access the Database


begin-quoteThe guide is so important to my job and I have helped so many patients as a result. I cannot thank you enough for having this extremely helpful information in one place.

Bonnie Snead
Insurance Authorization Manager
Inova Hematology Oncology
Fairfax, VA end-quote